Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday ...

The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...

Novartis has lost its legal challenge against the Inflation Reduction Act on Friday, making it the sixth drugmaker rejected ...

Lykos Therapeutics said it had a “productive” meeting with the FDA to discuss a path forward for its recently rejected PTSD ...

The FDA on Friday approved Astellas’ treatment for a type of gastric cancer, marketed as Vyloy (zolbetuximab). The approval ...

Two central nervous system disorder biotechs laid off employees recently. New York gene therapy startup Apertura and Boston ...

The European Medicines Agency’s human medicines committee again decided not to recommend the renewal of the conditional ...